Impact of policy changes and drug shortages on acamprosate and naltrexone use in Ontario, Canada
Konstantelos N, Tourchian N, McCormack D, Lecce P, Tadrous M, Gomes T. Drug Alcohol Depend. 2023; 242:109705. Epub 2022 Nov 19.
Publications
Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: population-based cohort study
Tadrous M, Chung H, Men S, Chu C, Campbell T, Juurlink DN, Kwong JC, Paterson JM, Gomes T. PLoS One. 2022; 17(10):e0273903. Epub 2022 Oct 20.
Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: a cross-sectional time-series analysis
Chang A, Chaudhry S, McCormack D, Gomes T, Shivji A, Tadrous M. Can Pharm J (Ott). 2022; Oct 12 [Epub ahead of print].
Estimated effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes
Buchan SA, Chung H, Brown KA, Austin PC, Fell DB, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC. JAMA Netw Open. 2022; 5(9):e2232760. Epub 2022 Sep 22.
Effectiveness of COVID-19 vaccines over time prior to Omicron emergence in Ontario, Canada: test-negative design study
Chung H, Austin PC, Brown KA, Buchan SA, Fell DB, Fong C, Gubbay JB, Nasreen S, Schwartz KL, Sundaram ME, Tadrous M, Wilson K, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Open Forum Infect Dis. 2022; Sep 7 [Epub ahead of print].
Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: a multiprovincial test-negative design study
Nasreen S, Febriani Y, García HAV, Zhang G, Tadrous M, Buchan SA, Righolt CH, Mahmud SM, Janjua NZ, Krajden M, De Serres G, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Clin Infect Dis. 2022; Aug 17 [Epub ahead of print].
Correlates of opioid use among Ontario long-term care residents and variation by pain frequency and intensity: a cross-sectional analysis
Iacono A, Campitelli MA, Bronskill SE, Hogan DB, Iaboni A, Maclagan LC, Gomes T, Tadrous M, Evans C, Gruneir A, Guan Q, Hadjistavropoulos T, Cotton C, Gill SS, Seitz DP, Ho J, Maxwell CJ. Drugs Aging. 2022; 39(10):811-27. Epub 2022 Aug 17.
Comparison of healthcare utilization between telemedicine and standard care: a propensity-score matched cohort study among individuals with chronic psychotic disorders in Ontario, Canada
Shakeri A, Chu C, Stamenova V, Fang J, Barker LC, Vigod SN, Bhatia RS, Tadrous M. Schizophr Bull Open. 2022; Jul 22 [Epub ahead of print].
The association between telemedicine use and changes in healthcare utilization and outcomes in patients with congestive heart failure: a retrospective cohort study
Chu C, Stamenova V, Fang J, Shakeri A, Tadrous M, Bhatia RS. JMIR Cardio. 2022; 6(2):e36442. Epub 2022 Jul 21.
Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study
Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109473. Epub 2022 Apr 26.